Last reviewed · How we verify
N-acetylcysteine 1000 mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
N-acetylcysteine 1000 mg (N-acetylcysteine 1000 mg) — Pontificia Universidad Catolica de Chile.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| N-acetylcysteine 1000 mg TARGET | N-acetylcysteine 1000 mg | Pontificia Universidad Catolica de Chile | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- N-acetylcysteine 1000 mg CI watch — RSS
- N-acetylcysteine 1000 mg CI watch — Atom
- N-acetylcysteine 1000 mg CI watch — JSON
- N-acetylcysteine 1000 mg alone — RSS
Cite this brief
Drug Landscape (2026). N-acetylcysteine 1000 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/n-acetylcysteine-1000-mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab